NUVB

Nuvation Bio Stock Analysis

AI Rating

Good
  • Quality3/10
  • Growth↑ 6/10
  • Momentum↑ 9/10
Nuvation Bio sales and earnings growth
NUVB Growth
Good
  • Revenue Y/Y↑ 1137.19%
  • EPS Y/Y↑ 77.52%
  • FCF Y/Y↓ -91.56%
Nuvation Bio gross and profit margin trends
NUVB Profitability
Neutral
  • Gross margin ↑ 54.30%
  • EPS margin↓ -813.10%
  • ROIC↓ -42.00%
Nuvation Bio net debt vs free cash flow
NUVB Risk
Great
  • Debt / Equity↓ 0.6
  • Debt / FCF↓ 0.6
  • Interest coverage↓ -29.6

Nuvation Bio stock volatility is in-line with the overall market. We give it a Great risk rating.

More Biotechnology stocks ↗